| 臺大學術典藏 |
2020-11-03T07:37:19Z |
Suggested cutoff tumor size for management of small EUS-suspected gastric gastrointestinal stromal tumors
|
Wang H.-P.; WEI-CHIH LIAO; Chen J.-H.; Yang C.-S.; Sun M.-S.; Cheng T.-Y.; Fang Y.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:52Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:49Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; MING-SHIANG WU; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:47Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
MING-SHIANG WU; Lee Y.-C.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:45Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L. |
| 臺大學術典藏 |
2020-11-02T02:04:33Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Lee Y.-C.; Wang W.-L.; Lee C.-T.; Tai C.-M.; MING-SHIANG WU; Bair M.-J.; Lin J.-T.; Sheu B.-S.; Wang H.-P.; Chang C.-C.; Yang T.-H.; Wu C.-Y.; Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wang Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Helicobacter Consortium; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen�VNegative Patients
|
Lin J.-T.; Wu C.-Y.; Hung H.-W.; Fang Y.-J.; Chen C.-C.; Chiang M.-F.; Wang C.-S.; Yang T.-H.; Wang W.-L.; Kao J.-H.; MING-SHIANG WU; Chang C.-Y.; Hsu Y.-C.; Mo L.-R. |
| 臺大學術典藏 |
2020-11-02T02:04:25Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chang C.-C.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Hsu Y.-C.; Chen C.-C.; Tseng C.-H.; Chen M.-J.; Lee Y.-C.; Chang C.-Y.; Bair M.-J.; Chen C.-C.; Fang Y.-J.; Liou J.-M. |
| 臺大學術典藏 |
2020-11-02T02:04:20Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; MING-SHIANG WU; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-02T02:04:19Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; Bair M.-J.; Lee Y.-C.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G. |
| 臺大學術典藏 |
2020-11-02T02:04:13Z |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection
|
Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:03Z |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; El-Omar E.M.; Chuang E.Y.; Lu T.-P.; Lin J.-T.; Wu J.-Y.; Chen Y.-N.; Hsu W.-F.; Chen C.-Y.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Chen C.-C.; Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:02Z |
Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profiles
|
MING-SHIANG WU; Chuang E.Y.; Fang Y.-J.; Liou J.-M.; Lu T.-P.; Panyod S.; Chang C.-M.; Chen C.-C.; Wu W.-K. |
| 臺大學術典藏 |
2020-07-05T03:14:28Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Wu M.-S.; Lee Y.-C.; Lin J.-T.; CHIA-TUNG SHUN; Yang U.-C.; Wang H.-P.; Lee J.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Fang Y.-J.; Chang C.-Y.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C. |
| 臺大學術典藏 |
2020-03-27T02:03:42Z |
Barium appendicitis
|
Fang Y.-J.; Wang H.-P.; Ho C.-M.; KAO-LANG LIU |
| 臺大學術典藏 |
2020-03-05T05:51:26Z |
Bleeding from ileal nodular lymphoid polyposis identified by capsule endoscopy
|
Wu J.-F.;Liou J.-H.;Huang-Chun Lien;Hsu W.-M.;Fang Y.-J.;Chang M.-H.;Ni Y.-H.; Wu J.-F.; Liou J.-H.; HUANG-CHUN LIEN; Hsu W.-M.; Fang Y.-J.; Chang M.-H.; Ni Y.-H. |
| 臺大學術典藏 |
2020-03-05T03:20:35Z |
Bleeding from ileal nodular lymphoid polyposis identified by capsule endoscopy
|
Wu J.-F.;Liou J.-H.;Lien H.-C.;Wen-Ming Hsu;Fang Y.-J.;Chang M.-H.;Ni Y.-H.; Wu J.-F.; Liou J.-H.; Lien H.-C.; WEN-MING HSU; Fang Y.-J.; Chang M.-H.; Ni Y.-H. |
| 臺大學術典藏 |
2020-02-11T03:54:01Z |
Barium appendicitis
|
Fang Y.-J.; Wang H.-P.; CHENG-MAW HO; Liu K.-L. |
| 國立臺灣科技大學 |
2020 |
Micrography QR Codes
|
Hung, S.-H.;Yao, C.-Y.;Fang, Y.-J.;Tan, P.;Lee, R.-R.;Sheffer, A.;Chu, H.-K. |
| 臺大學術典藏 |
2020 |
Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan
|
Liou J.-M.; Luo J.-C.; MING-SHIANG WU; Bair M.-J.; Kuo C.-C.; Weng Y.-J.; Chiu M.-C.; Yu C.-C.; Lee J.-Y.; Yang T.-H.; Chen C.-C.; Chen M.-J.; Fang Y.-J. |
| 臺大學術典藏 |
2020 |
Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan
|
Bair M.-J.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chen H.-H.; Tsai M.-H.; Hsieh C.-L.; Chiu M.-C.; Hu W.-H.; Kuo C.-C.; Yu C.-C.; Chen Y.-N.; Chen C.-C.; MING-SHIANG WU; Fang Y.-J.; Chen M.-J. |
| 臺大學術典藏 |
2019 |
Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
|
Hsu S.-J.; Chiu M.-C.; Fang Y.-J.; Yang T.-H.; Yu J.-J.; CHIEH-CHANG CHEN; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2019 |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial
|
Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wu M.-S.; El-Omar E.M.; Liou J.-M.;Chen C.-C.;Chang C.-M.;Fang Y.-J.;Bair M.-J.;Chen P.-Y.;Chang C.-Y.;Hsu Y.-C.;Chen M.-J.;Chen C.-C.;Lee J.-Y.;Yang T.-H.;Luo J.-C.;Chen C.-Y.;Hsu W.-F.;Chen Y.-N.;Wu J.-Y.;Lin J.-T.;Tzu-Pin Lu;Chuang E.Y.;El-Omar E.M.;Wu M.-S.;Taiwan Gastrointestinal Disease;Helicobacter Consortium; Liou J.-M.; Chen C.-C.; Chang C.-M.; Fang Y.-J.; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; TZU-PIN LU; Chuang E.Y. |
| 國立成功大學 |
2019 |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
Liu, C.-H.;Shih, Y.-L.;Yang, S.-S.;Lin, C.-L.;Fang, Y.-J.;Cheng, P.-N.;Chen, Chen C.-Y.;Peng, C.-Y.;Hsieh, T.-Y.;Chiu, Y.-C.;Su, T.-H.;Liu, C.-J.;Yang, H.-C.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H. |
